Thursday, November 10, 2022 Daily Archives

Drug Development – Developing Biologics for Respiratory Delivery

by

We bring you an informative on-demand drug development webinar, focusing on developing biologics for respiratory delivery. With drug discovery programmes increasingly focused on biological drug substances for both respiratory and systemic targets, the need to develop effective solutions for nasal and inhaled delivery is becoming increasingly vital for the industry. In this workshop, we will discuss the challenges and solutions alongside examples from real-world projects. Biologic and DNA-based modalities such as oligonucleotides, proteins, antibodies, and a range of other complex…

November 10, 2022

Benefits of Hollow Fiber Filter Cell Expansion

by

This webcast features: Stuart Gibb, PhD, Scientific Strategy Lead, Terumo Blood and Cell Technologies. Cell therapy requires cells to be healthy and active throughout the entire manufacturing process for optimal endpoint efficacy. A key part of this process is cell expansion. The Quantum Flex hollow-fiber filter technology provides an effective cell culture environment to provide ready access to fresh media, waste removal, and gas exchange over micrometer distances and works with suspension and adherent cell culture. In this environment, we…

November 10, 2022

Emergent: Compliance underway at Camden, but ‘it’s a long road ahead’

by

Emergent has invested in quality enhancement and improvement initiatives in response to an FDA warning letter but says there is still much to do. For Emergent BioSolution’s third quarter results, revenues from its contract development and manufacturing organization (CDMO) business unit dropped $76.4 million year-on-year. While much of this was due to lowered sales from COVID-19 vaccine clients AstraZeneca and J&J, the decrease also reflected reduced production at the firm’s Camden facility in Baltimore, Maryland, which recently received a warning…

November 10, 2022